Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

NCT01647516 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Ozanimod
DRUG: Placebo

Sponsor

Celgene